{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:27:26Z","timestamp":1785000446947,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006120","name":"Government of Japan Ministry of the Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.anndiagpath.2025.152475","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:55:21Z","timestamp":1742810121000},"page":"152475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Utility and limitations of Merlin immunohistochemistry for mesothelioma diagnosis in tissue sections and cell blocks"],"prefix":"10.1016","volume":"77","author":[{"given":"Kazuki","family":"Nabeshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152475_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.15796.1","article-title":"Multimodality treatment of malignant pleural mesothelioma","volume":"7","author":"Berzenji","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jtho.2024.01.017","article-title":"Immunotherapy is a good standard option for patients with malignant pleural mesothelioma, despite the real-world results from Australia","volume":"19","author":"Smesseim","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0015","series-title":"WHO classifcation of tumours","article-title":"Tumours of the pleura and pericardium","year":"2021"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajim.20246","article-title":"Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model","volume":"49","author":"Murayama","year":"2006","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/pin.13235","article-title":"Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations","volume":"72","author":"Nabeshima","year":"2022","journal-title":"Pathol Int"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/his.15007","article-title":"New developments in mesothelial pathology","volume":"84","author":"Churg","year":"2024","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.anndiagpath.2025.152475_bb0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/arpa.2023-0304-RA","article-title":"Guidelines for pathologic diagnosis of mesothelioma. 2023 update of the consensus statement from the International Mesothelioma Interest Group","volume":"148","author":"Husain","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152475_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncy.22509","article-title":"Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology","volume":"130","author":"Girolami","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152475_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1161995","article-title":"NF2 alteration in mesothelioma","volume":"5","author":"Sekido","year":"2023","journal-title":"Front Toxicol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41379-019-0309-6","article-title":"Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma","volume":"33","author":"Kinoshita","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2022.11.013","article-title":"Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: a multi-institutional study","volume":"175","author":"Sa-Ngiamwibool","year":"2023","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152475_bb0065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41379-022-01081-z","article-title":"Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100036","article-title":"Immunohistochemical demonstration of Merlin\/NF2 loss in mesothelioma","volume":"36","author":"Martin","year":"2023","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152475_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100030","article-title":"Neurofibromatosis type 2-Yes-associated protein and transcriptional coactivator with PDZ-binding motif dual immunohistochemistry is a reliable marker for the detection of neurofibromatosis type 2 alterations in diffuse pleural mesothelioma","volume":"36","author":"Li","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0080","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152475_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152475_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13073-021-00931-w","article-title":"Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma","volume":"13","author":"Meiller","year":"2021","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152475_bb0095","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","article-title":"Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152475_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12651","article-title":"Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival","volume":"14","author":"Quetel","year":"2020","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152475_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152475_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152004","article-title":"Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma\/sarcomatoid pleural mesothelioma with desmoplastic features","volume":"60","author":"Sa-Ngiamwibool","year":"2022","journal-title":"Ann Diagn Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T14:20:02Z","timestamp":1745590802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":23,"alternative-id":["S1092913425000401"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152475","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility and limitations of Merlin immunohistochemistry for mesothelioma diagnosis in tissue sections and cell blocks","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152475"}}